Learn how ATTR-CM is treated with medications that slow down the condition's progression and other therapies that reduce ...

Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine antimoniate administration has ...

除供应标准物质/泛影葡胺/MEGLUMINE相关化合物外，北京萘析生化科技有限公司还可为您提供2-叠氮-2-脱氧-D-葡萄糖、标样所 甲醇中对甲基苯酚 有机物监测标样/331903、色度等产品，公司有专业的客户服务团队，是您值得信赖的合作伙伴。

The purpose of the present study is to prepare a diatrizoate meglumine-loaded chitosan microsphere, which could be used to be investigated by ultrasonic imaging technique in vivo and would has water ...

Cutaneous leishmaniasis is an infectious disease that causes disfiguring scars, which are not eliminated by drugs available to the treatment. Besides, these marks lead to economic and social and ...

– AM-001 Study represents a pivotal milestone in Galmed's transition to Aramchol Meglumine, an improved formulation of its lead compound in advanced clinical development – Aramchol Meglumine ...

Galmed (GLMD) announced “positive” preliminary results from Part 1 of the Ph1 Bioavailability AM-001 Study of Aramchol Meglumine. Galmed has advanced Aramchol acid through six clinical trials ...

In Part 1 of AM-001, preliminary results demonstrate that a 400 mg dose of Aramchol Meglumine suspension achieved an area under the curve (AUC) nearly double that of Aramchol acid tablets. Based ...

Objective: To investigate the effect of ginkgo diterpene lactone meglumine injection on cognitive function in patients with acute ischemic stroke. Methods: This was a randomized, double-blind, placebo ...